This document discusses the prescription drug abuse epidemic in the United States. It provides statistics showing that nonmedical use of prescription opioids has nearly doubled from 1992 to 2003, with over 15 million Americans abusing prescription drugs in 2003. Emergency department visits involving opioid analgesics increased 111% from 2004 to 2008. Over 36,000 people died from drug overdoses in 2008. The economic costs of prescription painkiller abuse are over $70 billion per year. Factors contributing to the abuse of prescription drugs include their legal availability, perceived lower harm, and profitability of diversion. Strategies to address the epidemic include education, monitoring, abuse-deterrent formulations, and risk management programs.
The Practice and Theory of Alcohol & Drug Addiction Treatment at Delhi on Sa...Neil Paul
The workshop aims to identify core factors responsible for therapeutic success of Alcohol & Drug Addiction Treatmentregardless of theoretical orientation or psychiatric diagnosis
Substance abuse and addiction during adulthoodLydia Betsy
Definition of substance abuse, addiction and adulthood. Various stages of addiction, how one can overcome addiction and substance abuse, substance abuse and addiction across adulthood years. Effect on the mental health of an individual support with research studies.
The Practice and Theory of Alcohol & Drug Addiction Treatment at Delhi on Sa...Neil Paul
The workshop aims to identify core factors responsible for therapeutic success of Alcohol & Drug Addiction Treatmentregardless of theoretical orientation or psychiatric diagnosis
Substance abuse and addiction during adulthoodLydia Betsy
Definition of substance abuse, addiction and adulthood. Various stages of addiction, how one can overcome addiction and substance abuse, substance abuse and addiction across adulthood years. Effect on the mental health of an individual support with research studies.
Recreational drugs -
History
Types of Drugs
Classification according to drug abuse potential
Conventions on Drug Use
WHO drug report
CANNABIS LEGALISATION
Video - You can't OD on cannabis!
Week 4 Drug addiction, dopamine, and liking vs. wantingUbaldo Niña
The content of this presentation was taken from the:
MIT Open Course Ware http://ocw.mit.edu
ES.S10 Drugs and the Brain
This was made on behalf of the final requirements for:
CEIT321 Course in Middle East Technical University
Prescription Drug Misuse: Among Young Adultsamankhosa
A project that explains the prevalence of prescription drug misuse, specifically among the young adult population. Includes information on warning and behavioural signs of prescription drug abuse, commonly abused prescription drugs, cultural awareness, and related policies and prevention strategies.
outcome made by group of shahmir nawaz, adeen taquie, momin akbar and talmeez ur rehman
this outcome is aimed to help teenagers overcome drug addiction and to spread awarness among teeens about negative effects of drug abuse
Recreational drugs -
History
Types of Drugs
Classification according to drug abuse potential
Conventions on Drug Use
WHO drug report
CANNABIS LEGALISATION
Video - You can't OD on cannabis!
Week 4 Drug addiction, dopamine, and liking vs. wantingUbaldo Niña
The content of this presentation was taken from the:
MIT Open Course Ware http://ocw.mit.edu
ES.S10 Drugs and the Brain
This was made on behalf of the final requirements for:
CEIT321 Course in Middle East Technical University
Prescription Drug Misuse: Among Young Adultsamankhosa
A project that explains the prevalence of prescription drug misuse, specifically among the young adult population. Includes information on warning and behavioural signs of prescription drug abuse, commonly abused prescription drugs, cultural awareness, and related policies and prevention strategies.
outcome made by group of shahmir nawaz, adeen taquie, momin akbar and talmeez ur rehman
this outcome is aimed to help teenagers overcome drug addiction and to spread awarness among teeens about negative effects of drug abuse
Wsam Presentation For Opiate GuidelinesJKRotchford
CME presentation at WSMA annual meeting. Problematic opioid use, questioning the concept of "pseudo-addiction", seeing chemical dependency as somewhere well along the continuum of problematic opioid use.
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 .docxwellesleyterresa
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 1025
dictive Behaviors. Edited by Donovan
DM, Marlart GA. New York, Guilford,
1988
35. Grant I, Reed R: Neuropsychology of
alcohol and drug abuse, in Substance
Abuse and Psychology. Edited by Alter-
man A!. NewYork, Plenum, 1985
36. Vardy MM, Kay SR: LSD psychosis or
LSD-induced schizophrenia? A multi-
method inquiry. Archives of General
Psychiatry 40:877-883, 1983
37. Castellani 5, Petnie WM, Ellinwood E:
Drug-induced psychosis: neurobiologi-
cal mechanisms, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
38. McLellan AT, Woody GE, O’Brien CP:
Development ofpsychiatnic disorders in
drug abusers. New England Journal of
Medicine 301:1310-1314, 1979
39. Ellinwood E, Duarte-Escalante 0:
Chronic methamphetamine intoxication
in three species ofexperimental animals,
in Current Concepts on Amphetamine
Abuse. Edited by Ellinwood E, Cohen S.
Rockville, Md, National Institute of
Mental Health, 1972
40. BeIIDS: The experimental reproduction
of amphetamine psychosis. Archives of
General Psychiatry 30:35-40, 1973
41. Alterman A!: Substance abuse in psychi-
atnic patients, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
42. Kendler KS: A twin study of individuals
with both schizophrenia and alcoholism.
BritishJournal ofPsychiatry 147:48-53,
1985
43. Hesselbrock MN, Hesselbrock VM,
Tennen H, et al: Methodological con-
sidenations in the assessment of depres-
sion in alcoholics. Journal of Consulting
and Clinical Psychology 51:399-405,
1983
44. HimmelhochJM, Hill 5, Steunberg B, et
al: Lithium, alcoholism, and psychiatric
diagnosis. Journal of Psychiatric Treat-
ment and Evaluation 5:83-88, 1983
45. Mayfield D: Substance abuse in theaffec-
sive disorders, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
46. Schuckit MA: The importance of family
history ofaffective disorder in agroup of
young men. Journal of Nervous and
MentalDisease 170:530-535, 1982
47. Robertson MJ: Mental disorder among
homeless persons in the United States:
an overview of recent empirical liters-
tare. Administration in Mental Health
14:14-27, 1986
48. Blashfield BK Propositions regarding
the use of cluster analysis in clinical re-
search.JournalofConsultingand Clinical
Psychology 48:456-459, 1980
49. Blashfield RK, Money LC:The classifica-
tion of depression through cluster anal-
ysis. Comprehensive Psychiatry 20:516-
527, 1979
50. OverallJE, Hollister LE, Johnson M, et
al: Nosology ofdepression and differen-
tial response to drugs. JAMA 195:946-
948, 1966
51. Spitzer RL, Williams JBW: Having a
dream: a research study for DSM-IV.
Archives ofGeneral Psychiatry 45:871-
874, 1988
Treatment of Patients With
Psychiatric and Psychoactive
Substance Abuse Disorders
Fred C. Osher, M.D.
Lial L. Kofoed, M.D.
The treatment ofindividuals with
coexisting psychoactive substance
abuse and severepsy ...
Prescription drug abuse is an epidemic in the Appalachian region that is impacting public health, education, economic development and family life. This talk will examine epidemiologic factors associated with prescription and over-the-counter drug misuse. Commonly abused prescription and over-the-counter drugs will be discussed and safe patient and prescriber factors that can increase the risk of prescription drug abuse will be compared. The strengths and limitations of prescription-drug monitoring programs will be explained. Session participants will discuss actions they have taken in their community to fight prescription drug abuse.
Psychiatric Disorders in Chemically Dependent Individuals - October 2012Dawn Farm
This program provides an overview of co-occurring addiction and psychiatric illness, including standard diagnostic criteria, individual considerations for determining the appropriate course of treatment, available treatment interventions, and the perspectives of both the addict and the treatment provider on addiction and psychiatric illness. It is presented by Dr. Patrick Gibbons, LMSW, DO; Adjunct Clinical Instructor in Psychiatry at the University of Michigan; Medical Director of the WCHO Community Crisis Response Team; consultant with Pain Management Solutions in Ann Arbor; Medical Director of the Michigan Health Professionals Recovery Program, and Medical Director of Dawn Farm. This program is part of the Dawn Farm Education Series, a FREE, annual workshop series developed to provide accurate, helpful, hopeful, practical, current information about chemical dependency, recovery, family and related issues. The Education Series is organized by Dawn Farm, a non-profit community of programs providing a continuum of chemical dependency services. For information, please see http://www.dawnfarm.org/programs/education-series.
Unnecesary Medication Use in Long Term Care FacilitesDebbie Ohl
Meds are a key component in the clinical process.
The guidelines are intended to insure medication use is of value and necessary. T
Significant emphasis is placed on preventing and recognizing adverse drug reactions ASAP.
Consequently, surveyors will expect to see:
Rationale for use, Parameters for monitoring
Prompt recognition and evaluation of new onset problems and conditions worsening
Consideration for dose reduction and discontinuance as appropriate.
2. Controlled prescription drug abuse by Americans has
nearly doubled from
7.8 million in 1992 to 15.1 million in 2003
ED visits involving nonmedical use of opioid
analgesics
Increased 111% from 2004 to 2008 (CDC, SAMHSA)
Deaths due to prescription drug abuse
Increased 55% from 1999 to 2003
>36,000 people died of drug overdoses in 2008 (CDC)
Economic costs
Overall cost of painkiller abuse > $70 billion a year
Lost productivity costs ~ $42 billion a year
Criminal justice costs ~ $8.2 billion a year
Morbidity and Mortality Weekly Report. Center for Disease Control and Prevention. Emergency Department Visits Involving Nonmedical Use of
Selected Prescription drugs: United States, 2004-2008; 59(23). www.cdc.gov/mmwr. Accessed Feb 20, 2012.
Controlled Prescription Drug Abuse at Epidemic Level: The National Center on Addiction and Substance Abuse (CASA) at Columbia University. J
Pain & Palliative Care. 2006; 20(2): 61-61. http://www.casacolumbia.org. Accessed Feb 20, 2012.
3. Higher degree of purity
Made under strict rules and regulations
Known dose
Safer
Can avoid accidental overdosing
Legally available
Easy to obtain
Hard to detect in routine urine drug testing
Less social stigma
Less percieved potential harm
Certain legal biases in their favor
Illicit drug abuse – felony
Prescription drug abuse- misdemeanor
Prescription drugs are profitable
Cash most important factor in diversion of pain medications
Chandra A, Ozturk A. Health Professionals Beware of Prescription Pain Medication Abuse and
Diversion. Hospital Topics. 2004; 82: 34-36.
4. The Drug Abuse Warning Network (DAWN)
Public health information system that tracks the impact of drug
use, misuse, and abuse in the US by monitoring drug-related
hospital ED visits
DAWN describes nonmedical use of Rx or OTC drug as
Taking a higher-than-recommended dose
Taking a drug prescribed for another person
Documented misuse or abuse
Addiction (APS, AAPM, ASAM)
A primary, chronic, neuroiologic disease, with
genetic, psychosocial, and environmental factors influencing its
development and manifestations…
Characterized by behaviors that include one or more of the
following
Impaired control over drug use
Compulsive use
Continued use despite harm
Cravings
Hughes AA, Bogdan GM, Dart RC. Active Surveillance of Abused and Misused Prescription Opioids
Using Poison Center Data: A Pilot Study and Descriptive Comparison. J Clin Tox. 2007; 45: 144-151.
5. Category MOA Drug Classes Indications Common AEs
Opioids Antagonists at Prescription Acute or Analgesia, sedation, euphoria,
(narcotics) opioid receptors (μ, pain relievers chronic pain respiratory depression, physical
κ, δ) relief dependence, GI dysmotility,
pruritis
Sedative- Enhance effect of Sedatives, Sleep aide, CNS depression, slurred speech,
Hypnotics GABA-mediated BZDs, BARBs, insomnia, ataxia, incoordination, stupor,
chloride channels “downers” or seizure coma, cardiac dysrhythmia
sleeping pills disorders
Stimulants Enhance release of Amphetamine Narcolepsy, HTN, tachycardia, seizure,
catecholamines s,“uppers” or ADHD, hyperthermia, agitation,
(DA & NE); “speed”, short-term anorexia, ischemia,
stimulation of prescription weight rhabdomyolysis
peripheral α-and β- diet pills reduction
adrenergic receptors
Tranquilizers Enhance effect of Anxiolytics, Anxiety and CNS depression (less
GABA-mediated BZDs, muscle panic compromise in mental status
chloride channels relaxants disorders than with sedative-hypnotics),
and central DA slurred speech, ataxia,
receptors incoordination, stupor, coma,
cardiac dysrhythmia
Hernandez SH, Nelson LS. Prescription Drug Abuse: Insight into the Epidemic. Clin Pharma & Thera. 2010;
88(3): 307-317.
6. Hernandez SH, Nelson LS. Prescription Drug Abuse: Insight into the Epidemic. Clin Pharma &
Thera. 2010; 88(3): 307-317.
7. Illicit drug abuser Patient
Prescription drug abuser Neighbor
Druggie Healthcare Worker
Junkie Employee
Stoner Colleague
Drug Addict Friend
Abuser Family member
Abusing patient Spouse
Grandmother
Mother
Father
Child
Cory Phillips
8. Multidisciplinary approach
Assessment of substance use history
Set realistic goals for therapy
Evaluate and treat comorbid psychiatric disorders
Recognizing specific drug abusive behaviors
Use written agreements (controversial)
Patient may not be mentally competent for agreement
Guidelines for prescribing
Consider the therapeutic impact of tolerance
Apply pharmacological principles to treating pain
Use 12-step programs
Urine toxicology screens
Kirsh KL, Passik SD. Palliative Care of the Terminally Ill Drug Addict. Cancer Investigation. 2006;
24: 425-431.
9. Choose an opioid based on ATC dosing
Choose LA agents when possible
Limit or eliminate the use of SA or “breakthrough” doses
Use non-opioid adjuvants when possible and monitor for
compliance with those medications
Use nondrug adjuvants whenever possible
Relaxation techniques
Distraction
Biofeedback
Transcutaneous Nerve Stimulation (TNS)
Communication about thoughts and feelings of pain
Limit the amount of medication given at any one time
Utilize pill counts and urine toxicity screens as necessary
If compliance is suspect or poor, refer to an addiction specialist
Kirsh KL, Passik SD. Palliative Care of the Terminally Ill Drug Addict. Cancer Investigation. 2006;
24: 425-431.
10. Cross-sectional, multivariable, descriptive analysis
Age, gender, race, financial status, employment, current
smoking, drinking, past-year illicit drug use, depression, chronic
pain.
Veterans (N= 6,377)
Mean age 56.5 yo
Majority caucasian, unmarried, and unemployed
Found associations between prescription drug abuse and
Younger age
Depression or probable depression
Smoking
Illicit drug use
Chronic pain
Younger individuals using illicit drugs or having a history of
addiction or a mental illness at higher risk of abusing
prescription drugs
Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT, Olsin DW. The Association Between
Chronic Pain and Prescription Drug Abuse in Veterans. Pain Med. 2009; 10(3): 531-536.
11. Listening Considerations
Clinical judgment Prescriber creditials
Screening for abusers Indication
Controlled substance
Identifying the problem Non-controlled substance
Identifying and treating co- Abuse potential
morbidities Potential for harm
Exhibiting Alternative therapies
empathy/understanding Tolerance
Aiding in therapy Behaviors
modification Past medical history
Education on addiction Life expectancy
Safe and effective opioid
Referral to addiction services, prescribing?
counseling, recovery centers,
support groups, etc…
Hale, KM, Murawski MM, Huerta J. Pharmacist Roles in Combating Prescription Drug Abuse.
JAPhA. 2009; 49(5): 589-590.
12. Appearances may be decieving
Common characteristics
Escalated use
Continually running out of medication before scheduled follow-up
Frequently “losing” medication
Inability to clearly describe drug use pattern
Pseudoaddiction behaviors
Provider shopping
Pharmacists can identify from observation or databases
Frequent local ER visits
Several prescribers
No regular PCP or they are ‘out of town’
Seek treatment after hours or times when the clinic is typically busy
Scamming
Present as complimentary then, if resisted, threatening
Request of specific controlled substance
Avoid physical examination, history taking, diagnostic testing, or
provide a vague medical history
Gerhardt AM. Identifying the Drug Seeker: The Advanced Practice Nurse’s Role in Managing
Prescription Drug Abuse. JAANP. 239-243.
13. What are we doing
wrong? What can we do better?
Seek to help first
Lying to patients
Listen first, refuse later
Hanging up on patients What is the context in which this
patient is asking for this
medication?
Not listening to patients Does he/she have a home
pharmacy?
Gossiping about patients Can I verify the patient?
Is this a chronic pain/cancer
Not differintiating patient?
between patients who Does the patient need a dose
reduction or increase?
need help and true Does the patient need to be
weaned off this med?
addiction or diversion Does the patient need to see
his/her doctor?
GIVE THE BENEFIT OF THE
DOUBT
Cory Phillips
14. Active surveillance of abused and misused prescription
opioids using poison center data: A pilot study and
descriptive comparison
Poison Center data timely, geographic, and specific indicator
of opioid abuse
Poison Center data comparable to DAWN
Hydrocodone (55% v 39% cases); Oxycodone (39 % v 35% cases)
Poison Center highest rates of abuse in 18-25 yoa
DAWN ED visits highest in 35-44 yoa
Involve 2 substances (2nd being ETOH)
Kentucky leads nation in highest misuse and abuse rates
(DEA) followed byVirginia
Researched-Abuse, Diversion, and Addition-Related
Surveillance (RADARS®) Study
Abuse localized in rural, suburban, and small urban areas
Hydrocodone and ER/IR oxycodone most widely abused
drugs in the country
Abuse of all opioids grown throughout this study (3 ½ years)
Hughes AA, Bogdan GM, Dart RC. Active Surveillance of Abused and Misused Prescription Opioids Using Poison Center Data: A Pilot Study and
Descriptive Comparison. J Clin Tox. 2007; 45: 144-151.
Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz Alvaro. The Development of a Comprehensive Risk-Management Program for Prescription
15. Hughes AA, Bogdan GM, Dart RC. Active Surveillance of Abused and Misused Prescription Opioids
Using Poison Center Data: A Pilot Study and Descriptive Comparison. J Clin Tox. 2007; 45: 144-151.
16. Hughes AA, Bogdan GM, Dart RC. Active Surveillance of Abused and Misused Prescription Opioids
Using Poison Center Data: A Pilot Study and Descriptive Comparison. J Clin Tox. 2007; 45: 144-151.
17. Pharmacists (1st line)
Study on knowledge, attitudes, and professional practices of
pharmacists regarding addiction
Questionnaire (25 items; 484 pharmacists; Florida)
67.5% had participated in 2 h or less of addiction/substance abuse
education in pharmacy school
29.3% had no addition education
53.7% had never referred a patient to a drug treatment center
Closer monitoring and relations with pain patients
Increased awareness, education, and rehabilitation efforts
Abuse-deterrent and tamper-resistant opioid formulations
May be costly
Need more studies
Risk-Management Programs (last-line)
Drug Enforcement Agency (DEA)
Controlled Prescription Drug Abuse at Epidemic Level: The National Center on Addiction and
Substance Abuse (CASA) at Columbia University. J Pain & Palliative Care. 2006; 20(2): 61-61.
http://www.casacolumbia.org. Accessed Feb 20, 2012.
18. Schneider, JP, Matthews M, Jamison RN. Abuse-Deterrent and Tamper-Resistant Opioid
Formulations: What is their Role in Addressing Prescription Opioid Abuse? CNS Driugs. 2010;
24(10): 805-810.
19. NIDA Web Page for healthcare professionals
Publications, clinical practice, research
www.nida.nih.gov/medstaff.html.
Commonly Abused Prescription Drugs
Street names for Rx drugs, DEA schedule, intoxication
effects, and potential health consequences
www.nida.nih.gov/DrugPages/PrescripDrugsChart.html
The NIDA Research Report- Prescription Drugs: Abuse and
Addiction
www.nida.nih.gov/ResearchReports/Prescription/Prescriptio
n.html
Monitoring the Future
An ongoing study of the behaviors, attitudes, and values of
American secondary school students, college students, and
young adults
Provides information on the latest drug use trends
www.monitoringthefuture.org.
Volkow ND. Teen Prescription Drug Abuse: A Major Health Concern. Tn Med. 2009: 28-29.
21. Who will you turn away?
Who will you turn in?
Who will you help?
http://www.sheknows.com/sheknows-
cares/articles/806066/emotional-support-for-
breast-cancer-patients-and-survivors-fosters-hope
Who will you help?
Who will you turn away?
Who will you turn in?
http://opioids.com/oxycodone/oxycon.html
22. 1. Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT, Olsin DW. The Association Between Chronic Pain and
Prescription Drug Abuse in Veterans. Pain Med. 2009; 10(3): 531-536.
2. Chandra A, Ozturk A. Health Professionals Beware of Prescription Pain Medication Abuse and Diversion. Hospital
Topics. 2004; 82: 34-36.
3. Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz Alvaro. The Development of a Comprehensive Risk-
Management Program for Prescription Opioid Analgesics: Researched Abuse, Diversion, and Addiction-Related
Surveillance (RADARS). Pain Med. 2007; 8(2): 157-170.
4. Controlled Prescription Drug Abuse at Epidemic Level: The National Center on Addiction and Substance Abuse
(CASA) at Columbia University. J Pain & Palliative Care. 2006; 20(2): 61-61. http://www.casacolumbia.org. Accessed
Feb 20, 2012.
5. Gerhardt AM. Identifying the Drug Seeker: The Advanced Practice Nurse’s Role in Managing Prescription Drug
Abuse. JAANP. 239-243.
6. Hale, KM, Murawski MM, Huerta J. Pharmacist Roles in Combating Prescription Drug Abuse. JAPhA. 2009; 49(5):
589-590.
7. Hernandez SH, Nelson LS. Prescription Drug Abuse: Insight into the Epidemic. Clin Pharma & Thera. 2010; 88(3):
307-317.
8. Hughes AA, Bogdan GM, Dart RC. Active Surveillance of Abused and Misused Prescription Opioids Using Poison
Center Data: A Pilot Study and Descriptive Comparison. J Clin Tox. 2007; 45: 144-151.
9. Kehoe Jr WA. Substance Abuse: New Numbers Are a Cause for Action. Ann Pharma. 2008; 42: 270-272.
10. Kirsh KL, Passik SD. Palliative Care of the Terminally Ill Drug Addict. Cancer Investigation. 2006; 24: 425-431.
11. Lafferty L, Hunter TS, Marsh WA. Knowledge, Attitudes, and Practices of Pharmacists Concerning Prescription
Drug Abuse. J Psychoactive Drugs. 2006; 28(3): 229-232.
12. Morbidity and Mortality Weekly Report. Center for Disease Control and Prevention. Emergency Department Visits
Involving Nonmedical Use of Selected Prescription drugs: United States, 2004-2008; 59(23). www.cdc.gov/mmwr.
Accessed Feb 20, 2012.
13. Schneider, JP, Matthews M, Jamison RN. Abuse-Deterrent and Tamper-Resistant Opioid Formulations: What is
their Role in Addressing Prescription Opioid Abuse? CNS Drugs. 2010; 24(10): 805-810.
14. Volkow ND. Teen Prescription Drug Abuse: A Major Health Concern. Tn Med. 2009: 28-29.
15. Wysowski DK. Surveillance of Prescription Drug-Related Mortality Using Death Certificate Data. Drug Safety.
2007; 30(6): 533-540.
Editor's Notes
MMWRPrescription drugs involved in 20,000 cases
HC Professionals Beware of Prescription Medication Abuse and DiversionSemisynthetic opioids not converted to morphine demonstrate variable urine test detection and will usually not test positive at standard doses (must usually be >2000 ng/mL conc for detection)Codeine and heroine readily detectable.
Drug-facilitated assaultDiversion- some of are pts are put on an addicting mediction which helps them and taken off or their doctor does not think they should get it and so they are going to buy it elsewhereAddiction- behavioral syndrome characterized by psychologic dependence and abnormal drug-related behaviorsPseudoaddiction- Usually result of undertreated pain; attempts to obtain more medications as a result of unrelieved pain or fear of running out of analgesicsTolerance- Learned cellular response requiring higher dose of analgesic to achieve the level of pain relief previously accomplished by a smaller dosePhysical Drug Dependence- normal physiological response to continuous opioid therapy, with the appearance of withdrawal syndrome with the drug is abruptly discontinued
Prescription Drug Abuse: Insight Into the Epidemic
NSDUH (National Survey on Drug Use and Health)Marijuana > Pain relievers > Inhalants > Tranquilizers/Hallucinogens/Inhalents
Base decision on judgment and situationKnow your bad doctors and bad prescriptionsPsychosocial and family counseling
Eliminate SA so they do not use more than prescribed and not controlled ATC. Palliative Care of the Terminally Ill Drug Addict
Addiction- behavioral syndrome characterized by psychologic dependence and abnormal drug-related behaviorsPseudoaddiction- Usually result of undertreated pain; attempts to obtain more medications as a result of unrelieved pain or fear of running out of analgesicsTolerance- Learned cellular response requiring higher dose of analgesic to achieve the level of pain relief previously accomplished by a smaller dosePhysical Drug Dependence- normal physiological response to continuous opioid therapy, with the appearance of withdrawal syndrome with the drug is abruptly discontinued
Knowledge, Attitudes, and Practices of Pharmacists Regarding Addiction
Remoxy- ER Oxycodone contained in highly viscous liquid formulation matrix. Intended to resist abuse by crushing, freezing and crushing, or dissolution in water, alcohol, or common liquids. Gel is vicous sucrose acetate isobutyrate which is designed to be difficult to snort or inject. Embeda- morphine suphate with sequestered naltrexone Capsule with naltrexone core that is not released unless unless crushed or dissolved, naltrexone is released and mixed with morphine, thus blunting theeuphoric effects of morphine. (approved 2009) Tramadol for mod-sever nociceptive/neuropathic pain- still abused Acurox- IR oxycodone fomulated with niacin which causes unpleasant effects (warmth, flushing, itching, sweating, chills) if excess number of tablets are swallowed.